Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANJIVANI PA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANJIVANI PA   MYLAN
EQUITY SHARE DATA
    SANJIVANI PA
Mar-23
MYLAN
Dec-18
SANJIVANI PA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs683,978-   
Low Rs252,190-   
Sales per share (Unadj.) Rs35.51,830.6-  
Earnings per share (Unadj.) Rs4.549.7-  
Cash flow per share (Unadj.) Rs5.4392.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs-3.11,980.4-  
Shares outstanding (eoy) m10.00514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.7 77.6%   
Avg P/E ratio x10.362.0 16.6%  
P/CF ratio (eoy) x8.67.9 109.3%  
Price / Book Value ratio x-15.11.6 -970.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m4641,586,770 0.0%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m290-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m355941,863 0.0%  
Other income Rs m90-   
Total revenues Rs m364941,863 0.0%   
Gross profit Rs m53243,719 0.0%  
Depreciation Rs m9176,354 0.0%   
Interest Rs m445,300 0.0%   
Profit before tax Rs m4922,065 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4-3,510 -0.1%   
Profit after tax Rs m4525,575 0.2%  
Gross profit margin %14.825.9 57.2%  
Effective tax rate %8.8-15.9 -55.0%   
Net profit margin %12.72.7 468.1%  
BALANCE SHEET DATA
Current assets Rs m83525,936 0.0%   
Current liabilities Rs m227383,465 0.1%   
Net working cap to sales %-40.515.1 -268.0%  
Current ratio x0.41.4 26.6%  
Inventory Days Days5384 63.6%  
Debtors Days Days20,452,42393 21,917,651.9%  
Net fixed assets Rs m127182,706 0.1%   
Share capital Rs m100501 19.9%   
"Free" reserves Rs m-1310-   
Net worth Rs m-311,018,924 -0.0%   
Long term debt Rs m81,099,746 0.0%   
Total assets Rs m2102,733,150 0.0%  
Interest coverage x14.81.5 993.3%   
Debt to equity ratio x-0.21.1 -22.9%  
Sales to assets ratio x1.70.3 490.3%   
Return on assets %23.22.6 894.0%  
Return on equity %-146.92.5 -5,852.8%  
Return on capital %-229.43.2 -7,213.8%  
Exports to sales %63.80-   
Imports to sales %3.50-   
Net fx Rs m2140-   
CASH FLOW
From Operations Rs m47195,719 0.0%  
From Investments Rs m-10-101,165 0.0%  
From Financial Activity Rs m-37-91,177 0.0%  
Net Cashflow Rs m01,621 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare SANJIVANI PA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SANJIVANI PA With: SHUKRA PHARMA  LUPIN  GUJ.TERC LAB  OMKAR PHARMACHEM  S.S.ORGANICS  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.